Thought of as the premier conference in the immunoglobulin and biologics space, the bustling Immunoglobulin National Society (IgNS) 12th national conference took place at the Sheraton Denver Downtown from Oct. 5 to 8, 2023.
The four-day meeting welcomed more than 1,200 attendees who had access to more than 50 clinical and business sessions. Educational programs, keynote speakers, exhibits, and networking were geared toward nurses, pharmacists, and physicians who are on the front lines of treating myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, common variable immunodeficiency, primary immune thrombocytopenia, immunologic recurrent pregnancy loss, dermatomyositis, polymyositis, and juvenile dermatomyositis, plus other conditions.
Click above for our post-conference wrap-up report.
